Feedback / Questions
psilocybin (COMP360) - Compass Pathways
https://www.globenewswire.com/news-release/2024/05/08/2877609/0/en/Compass-Pathways-announces-durable-improvement-in-symptoms-through-12-weeks-in-open-label-phase-2-study-of-COMP360-psilocybin-in-post-traumatic-stress-disorder.html
May 8, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next